Skip to main content
OpenTrials
Active, not recruiting

NCT Number: NCT07797972

Prospective Clinical Evaluation of Posterior Single-tooth Zirconia Ceramic Restorations

This prospective, controlled, open clinical product surveillance trial will evaluate the performance of posterior zirconia ceramic crowns over 24 months

Active, not recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Penn Dental Medicine

Philadelphia, Pennsylvania, 19104, United States

About this study

This prospective, controlled, open clinical product surveillance trial will evaluate the performance of posterior zirconia ceramic crowns over 24 months. A total of 40 indirect full-coverage crowns will be fabricated from zirconia ceramic (IPS e.max® ZirCAD Prime Esthetic, Ivoclar Vivadent, Schaan, Liechtenstein) and cemented with ZirCAD Cement (Ivoclar Vivadent), a resin modified glass ionomer luting cement. Clinical evaluation parameters restorations in terms of fracture resistance, marginal adaptation, shade/color match, and other complications will be assessed at baseline and then 6 months, 1 year, and 2 years postoperatively. Descriptive statistics will be used and survival analysis will be estimated with Kaplan-Meier survival analysis.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • At least 18 years of age (selected regardless of sex, race or other ethnic characterization)
  • Vital or endodontically treated tooth
  • Antagonist present
  • Classify as ASA I or ASA II according to the American Society of Anesthesiologists (ASA)
  • In need of an indirect full-coverage restoration (crown) on at least one posterior tooth (premolar or molar)
  • Fulfilling all medical and dental requirements for preparation of a full-coverage crown
  • Angle Class I occlusal relationship with a minimum of 20 remaining teeth
  • Adequate intra-arch space allowing for satisfactory restoration of the abutment teeth. If opposing teeth have supra-erupted, an ideal occlusal plane will be restored by enameloplasty. In cases of severe supra-eruption, patients will need to consent to alternative means of restoring an ideal plane of occlusion. This may involve surgical crown lengthening and/or restoration of the tooth. Otherwise, they will be excluded from the study.
  • Dentition free of active periodontal disease (probing depth and attachment levels at within normal limits, no furcation involvement, no mobility). Individuals meeting other criteria but presenting with active periodontal disease will be referred to the Post-Graduate Periodontal Clinic for treatment and subsequently re-screened.
  • Willingness and ability to comply with the pre- and post-operative diagnostic and clinical evaluations required for the study.
  • Willingness and ability (including financial) to comply with the final restorative treatment plan that will be accomplished upon completion of participation in the study.
  • Willingness and ability to understand and comply with Institutional Review Board (IRB)/Ethics Committee requirements as outlined in consent forms, which have to be signed by the patients.
  • Subjects are responsible for payment of regular dental procedures.

Exclusion criteria

  • Severe wear facets and/or parafunctional activities such as clenching or nocturnal bruxism
  • Pulpitis, no hypersensitivity on biting and temperature (visual analog scale <3)
  • Insufficient endodontic treatment
  • Periapical pathology
  • Pregnancy during the treatment phase
  • Significant medical conditions or drug use that could interfere with evaluation (i.e., narcotics, NSAIDs)
  • Medical conditions that preclude the subject from carrying out oral hygiene regimens (i.e., severe arthritis affecting the hands)
  • Social history that indicates a risk of poor compliance (i.e., history of alcohol or drug abuse) with proper maintenance of restoration

Treatment and study plan

IPS e.max® ZirCAD Prime Esthetic

Combination Product

Full-coverage crowns will be fabricated from zirconia ceramic discs (IPS e.max® ZirCAD Prime Esthetic, Ivoclar Vivadent, Schaan, Liechtenstein) and cemented with ZirCAD Cement (Ivoclar Vivadent) a resin modified glass ionomer luting cement.

Primary outcomes

  1. Survival analysis

    Time frame: From day 1 of crown placement to follow-up visits at 6, 12, and 24 months.

    Survival analysis will be estimated using Kaplan-Meier survival analysis. Based on the following variables; restoration loss and FDI criteria (Marginal fit, Shade/Color Match, and Incidence of complications)

Sponsors and collaborators

Lead sponsor

University of Pennsylvania

Other

Collaborators

  • Ivoclar Vivadent AG

Registry information

Important dates

Study start
2022
Primary completion
2026
Study completion
2026
First posted
Sep 1, 2026
Registry last updated
Sep 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.